In the last trading session, 2.17 million Mind Medicine Inc (NASDAQ:MNMD) shares changed hands as the company’s beta touched 1.76. With the company’s per share price at $7.18 changed hands at -$0.45 or -5.90% during last session, the market valuation stood at $526.52M. MNMD’s last price was a discount, traded about -70.19% off its 52-week high of $12.22. The share price had its 52-week low at $4.54, which suggests the last value was 36.77% up since then.
Analysts gave the Mind Medicine Inc (MNMD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.10. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MNMD as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Mind Medicine Inc’s EPS for the current quarter is expected to be -0.28.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD was in red as seen at the end of in last trading. With action -27.40%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 3.16%, with the 5-day performance at -27.40% in the red. However, in the 30-day time frame, Mind Medicine Inc (NASDAQ:MNMD) is -0.14% down.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 48.71% from its current market value. According to analyst projections, MNMD’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -94.99% plunge from its current level, while the stock would need to soar -94.99% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 2.29%. The 2025 estimates are for Mind Medicine Inc earnings to increase by 41.32%, but the outlook for the next 5-year period is at 14.93% per year.
MNMD Dividends
Mind Medicine Inc is expected to release its next quarterly earnings report in March.
holds the second largest percentage of outstanding shares.
Among Mutual Funds, the top two as of Nov 30, 2024 were iShares Russell 2000 ETF and Vanguard Extended Market Index Fund . With 2.03 shares estimated at $14.58 million under it, the former controlled 2.77% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.43% of the shares, roughly 1.05 shares worth around $7.55 million.
